Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPX056 PK/PD in MS Spasticity
NCT00488839Phase 3Completed
- Sponsor
- Impax Laboratories
- Start
- Jun 2007
- Primary completion
- May 2008
- Modality
- Drug Delivery Systems
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of IPX056 in spasticity (4 arms), sponsored by Impax Laboratories. Primary endpoint: Total Ashworth Score at 12 hours. Started Jun 2007; status: completed.
02
Drugs
IPX056
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT00488839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488839.